The Role of Combination Therapies in Optimizing Diabetes Management

Rabia Amin; Yasir Ali; Sana Idrees; Ahmad Bilal Ashraf; Bushra Safeer; Adnan Manzoor

doi:10.70749/ijbr.v2i02.244

Authors

Rabia Amin Department of Radiology, Bahria International Hospital, Lahore, Punjab, Pakistan.
Yasir Ali Faculty of Nursing and Midwifery, Ziauddin University, Karachi, Sindh, Pakistan.
Sana Idrees Department of Surgery, Masood Hospital, Lahore, Punjab, Pakistan.
Ahmad Bilal Ashraf Department of Pediatric Medicine, Allama Iqbal Medical College/Jinnah Hospital, Lahore, Punjab, Pakistan.
Bushra Safeer Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, KP, Pakistan.
Adnan Manzoor Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v2i02.244

Keywords:

Type 2 Diabetes, Combination Therapy, Glycemic Control, Adherence, Pakistan

Abstract

Objective: To evaluate the efficacy of combination therapies in optimizing diabetes management among patients with type 2 diabetes (T2D) in Pakistan, focusing on glycemic control and treatment adherence. Methodology: A prospective, observational study was conducted at the Department of Medicine, Jinnah Hospital, Lahore from March 2023 to March 2024. A total of 250 patients were randomly assigned to either the intervention group (combination therapy) or the control group (standard therapy). Glycaemic control was assessed using HbA1c levels, while adherence was measured using the Diabetes Self-Management Questionnaire (DSMQ). Statistical analyses, including t-tests, were performed with a significance level set at (p < 0.05). Results: The intervention group showed significantly lower HbA1c levels (mean ± SD: 6.7 ± 1.0%) compared to the control group (8.1 ± 0.9%; \ (p < 0.0001\)). Adherence scores were higher in the intervention group (87 ± 8%) than in the control group (72 ± 10%; \ (p < 0.0001\)). The intervention group also had better weight control (72.5 ± 10.2 kg vs. 78.3 ± 12.1 kg; \(p < 0.05\)) and maintained better blood pressure profiles. These findings demonstrate the superior efficacy of combination therapies in achieving improved glycemic outcomes and adherence. Conclusion: Combination therapies offer significant advantages in managing T2D in Pakistan, improving glycemic control and adherence. The study underscores the need for broader adoption of combination therapies and further research on their cost-effectiveness and long-term outcomes.

References

Matthews, D., Del Prato, S., Mohan, V., Mathieu, C., Vencio, S., Chan, J. C. N., Stumvoll, M., & Paldánius, P. M. (2020). Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes. Diabetes Therapy, 11(11), 2465–2476. https://doi.org/10.1007/s13300-020-00926-7

Yoo, S.-J., Chang, S.-A., Sohn, T. S., Kwon, H.-S., Lee, J. M., Moon, S., Proot, P., Paldánius, P. M., & Yoon, K. H. (2020). Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2020.0173

Kim, J. Y., & Kim, N. H. (2023). Initial Combination Therapy in Type 2 Diabetes. Endocrinology and Metabolism, 39(1), 23–32. https://doi.org/10.3803/EnM.2023.1816

Nawaz, M. S., Rafique, H. S., Malik, T., Wahab, M. U., Chughtai, A. U. H., Nawaz, M. S., & Butt, M. D. (2023). CURRENT TRENDS AND AVAILABILITY OF INJECTABLE THERAPY IN PAKISTAN FOR MANAGEMENT OF DIABETES MELLITUS. International Journal of Pharmacy & Integrated Health Sciences, 4(1). https://doi.org/10.56536/ijpihs.v4i1.63

Baig, M. U., & Farooq, A. (2023). Awareness of Use of GLP-1 agonists in the treatment of Diabetes Mellitus in Pakistan. Journal of the Pakistan Medical Association, 73(8), 1769–1769. https://doi.org/10.47391/jpma.8210

Ansari, R. M., Harris, M., Hosseinzadeh, H., & Zwar, N. (2021). Healthcare Professionals’ Perspectives of Patients’ Experiences of the Self-Management of Type 2 Diabetes in the Rural Areas of Pakistan: A Qualitative Analysis. International Journal of Environmental Research and Public Health, 18(18), 9869. https://doi.org/10.3390/ijerph18189869

Javaid, Z., Imtiaz, U., Khalid, I., Saeed, H., Khan, R. Q., Islam, M., Saleem, Z., Sohail, M. F., Danish, Z., Batool, F., & Anwer, N. (2019). A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan. BMC Health Services Research, 19(1). https://doi.org/10.1186/s12913-019-4274-z

Malik, M., Hussain, A., Aslam, U., Hashmi, A., Vaismoradi, M., Hayat, K., & Jamshed, S. (2022). Effectiveness of Community Pharmacy Diabetes and Hypertension Care Program: An Unexplored Opportunity for Community Pharmacists in Pakistan. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.710617

Majeed, Y., Shaukat, M. B., Abbasi, K. Y., & Ahmad, M. A. (2021). Indigenous plants of Pakistan for the treatment of diabetes: A review. Agrobiological Records, 4, 44-63. https://doi.org/10.47278/journal.abr/2020.028

Waseem, H., Bangash, A., & Aamir, A. (2023). From control to remission: Empowering change in type 2 diabetes care. Journal of Pakistan Medical Association, 73(12), 2538–2538. https://doi.org/10.47391/jpma.10076

Hassani, S. S., Fallahi, A., Esmaeili, S. S., & Fesharaki, M. G. (2019). The Effect of Combined Therapy with Fenugreek and Nutrition Training Based on Iranian Traditional Medicine on FBS, HgA1c, BMI, and Waist Circumference in Type 2 Diabetic Patients: a Randomized Double Blinded Clinical Trial. Journal of Advances in Medical and Biomedical Research, 27(120), 37–42. https://doi.org/10.30699/jambs.27.120.37

Jamali, A., Ram, N., Karim, S., Sattar, S., Rashid, M. S., & Islam, N. (2023). Prescribing patterns of antidiabetic drugs and glycaemic control in type 2 diabetes patients visiting tertiary care hospital based in Karachi, Pakistan. International Journal of Community Medicine and Public Health, 10(11), 4082–4088. https://doi.org/10.18203/2394-6040.ijcmph20233433

Bukhsh, A., Khan, T. M., Sarfraz Nawaz, M., Sajjad Ahmed, H., Chan, K. G., & Goh, B. H. (2019). Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity, 12, 1409–1417. https://doi.org/10.2147/DMSO.S209711

Weinberg Sibony, R., Segev, O., Dor, S., & Raz, I. (2023). Drug Therapies for Diabetes. International Journal of Molecular Sciences, 24(24), 17147. https://doi.org/10.3390/ijms242417147

Martinez, A., & Goldman, J. D. (2022). Efficacy and Durability of Combination Treatment With Glucagon-Like Peptide-1 Receptor Agonists and Basal Insulin. ADCES in Practice, 10(6), 42–45. https://doi.org/10.1177/2633559x221127992